Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Preferred Shares (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Preferred Shares for 3 consecutive years, with $1804.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Preferred Shares changed 0.0% year-over-year to $1804.0, compared with a TTM value of $1804.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $1804.0, changed 0.0% over the prior year.
  • Preferred Shares was $1804.0 for Q3 2025 at Xenetic Biosciences, roughly flat from $1804.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $1804.0 in Q2 2023 and bottomed at $970.0 in Q1 2023.
  • Average Preferred Shares over 3 years is $1652.4, with a median of $1804.0 recorded in 2023.
  • Peak annual rise in Preferred Shares hit 85.98% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Preferred Shares stood at $1804.0 in 2023, then changed by 0.0% to $1804.0 in 2024, then changed by 0.0% to $1804.0 in 2025.
  • Business Quant data shows Preferred Shares for XBIO at $1804.0 in Q3 2025, $1804.0 in Q2 2025, and $1804.0 in Q1 2025.